Table of Contents
Industry Standard Research’s (ISR) “2013 CRO Quality Benchmarking – Phase IV Service Providers” report provides pharmaceutical sponsors and clinical service providers an independent and comprehensive analysis of CRO service quality to assist with the outsourcing of Phase IV clinical trial activities.This year, ISR’s Phase IV report includes data from 208 unique service evaluations across 27 Phase IV
What you will learn in this report:
- Performance of 27 Phase IV CROs, 7 of which received in-depth profiles, measured across 26 critical dimensions of service quality
- How sponsors make their clinical outsourcing decisions, including which service attributes drive selection
- Study sponsors’ satisfaction, willingness to recommend, and likelihood of repeat use for the 27 included Phase IV CROs
How you can use this report:
For study sponsors, this report offers insight into CRO service quality and empowers you to make more informed late phase outsourcing decisions by providing evaluation and selection tools that will lead to better service experiences.
For clinical service providers, this report offers insight into your service quality and your competitors’ quality that will allow you to compete more effectively, deliver higher quality services, and better understand the needs of your customers.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...
This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...